← FDA DRUG APPROVALS

FDA ANDA · ANDA087011

QUINIDINE SULFATE

Sponsor: DAVA PHARMS INC

APPLICATION
ANDA087011
TYPE
ANDA
ORIGINAL APPROVAL
1979-08-29
LATEST ACTION
1999-03-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

QUINIDINE SULFATEDiscontinued
QUINIDINE SULFATE 200MG · TABLET · ORAL

Approval history

1999-03-12Manufacturing (CMC) · Supplement 17AP
1999-02-25Labeling · Supplement 18AP
1996-03-18Labeling · Supplement 16AP
1994-11-08Manufacturing (CMC) · Supplement 15AP
1993-08-06Manufacturing (CMC) · Supplement 14AP
1989-03-23Labeling · Supplement 13AP
1985-09-13Manufacturing (CMC) · Supplement 10AP
1984-03-26Manufacturing (CMC) · Supplement 8AP
1982-04-23Manufacturing (CMC) · Supplement 4AP
1982-04-23Manufacturing (CMC) · Supplement 2AP
1982-04-23Manufacturing (CMC) · Supplement 5AP
1982-04-23Manufacturing (CMC) · Supplement 3AP
1982-04-23Manufacturing (CMC) · Supplement 1AP
1979-08-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →